Synthetic Human Secretin in Children With Autism
Public ClinicalTrials.gov record NCT00036244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy, Safety and Tolerability of RG1068 (Synthetic Human Secretin) in Children With Autism
Study identification
- NCT ID
- NCT00036244
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Repligen Corporation
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- RG1068 (Synthetic Human Secretin) Drug
Drug
Eligibility (public fields only)
- Age range
- 32 Months to 59 Months
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2002
- Primary completion
- Not listed
- Completion
- Dec 31, 2003
- Last update posted
- Aug 4, 2005
2002 – 2004
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research Center | Phoenix | Arizona | — | — |
| UCLA Pediatric Neurology | Los Angeles | California | 90095-1752 | — |
| Children's Hospital and Research Center at Oakland | Oakland | California | 94609 | — |
| 1st Allergy & Clinical Research Center | Centennial | Colorado | 80112 | — |
| Alachua Family Psychiatry | Gainesville | Florida | 32607 | — |
| Miami Children's Hospital | Miami | Florida | — | — |
| Riley Children's Hospital | Indianapolis | Indiana | 46202-5200 | — |
| The Clinical Trials Center:A Division of Children's Hospital | Metairie | Louisiana | 70006 | — |
| Hardy Healthcare Associates | Hingham | Massachusetts | — | — |
| Children's Hospital of Michigan | Detroit | Michigan | 48201 | — |
| University of Medicine and Dentistry of New Jersey | Newark | New Jersey | 07107 | — |
| Schneider Children's Hospital | New Hyde Park | New York | — | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| Children's Biomedical Center of Utah | Sandy City | Utah | 84093 | — |
| Puget Sound Neurology | Edmonds | Washington | 98026 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00036244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2005 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00036244 live on ClinicalTrials.gov.